Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
43,045,451
-
Share change
-
+384,691
-
Total reported value
-
$10,580,189,287
-
Put/Call ratio
-
32%
-
Price per share
-
$245.66
-
Number of holders
-
501
-
Value change
-
+$95,192,070
-
Number of buys
-
235
-
Number of sells
-
205
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q3 2022
As of 30 Sep 2022,
ABIOMED INC - COMMON STOCK (ABMD) was held by
501 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,045,451 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, PRIMECAP MANAGEMENT CO/CA/, WELLINGTON MANAGEMENT GROUP LLP, GENERATION INVESTMENT MANAGEMENT LLP, RENAISSANCE TECHNOLOGIES LLC, BROWN CAPITAL MANAGEMENT LLC, and Winslow Capital Management, LLC.
This page lists
501
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.